Ligand Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world.

CEO

Todd Christopher Davis

CEOTodd Christopher Davis

Employees

Employees47

Headquarters

Jupiter, Florida

HeadquartersJupiter, Florida

Founded

1987

Founded1987

Employees

Employees47

LGND Key Statistics

Market cap

5.71B

Market cap5.71B

Price-Earnings ratio

30.61

Price-Earnings ratio30.61

Dividend yield

—

Dividend yield—

Average volume

230.92K

Average volume230.92K

High today

$290.00

High today$290.00

Low today

$285.21

Low today$285.21

Open price

$288.09

Open price$288.09

Volume

141.86K

Volume141.86K

52 Week high

$326.63

52 Week high$326.63

52 Week low

$156.91

52 Week low$156.91

Stock Snapshot

With a market cap of 5.71B, Ligand Pharmaceuticals(LGND) trades at $286.29. The stock has a price-to-earnings ratio of 30.61.

On 2026-08-23, Ligand Pharmaceuticals(LGND) stock moved within a range of $285.21 to $290.00. With shares now at $286.29, the stock is trading +0.4% above its intraday low and -1.3% below the session's peak.

Trading volume for Ligand Pharmaceuticals(LGND) stock has reached 141.86K, versus its average volume of 230.92K.

The stock's 52-week range extends from a low of $156.91 to a high of $326.63.

LGND News

Benzinga 2d

$100 Invested In Ligand Pharmaceuticals 10 Years Ago Would Be Worth This Much Today - Benzinga

...

Simply Wall St 4d

Reaffirmed 2026 Guidance After Strong Q2 Could Be A Game Changer For Ligand Pharmaceuticals

In August 2026, Ligand Pharmaceuticals reported past second-quarter 2026 results showing revenue of US$63.69 million and net income of US$48.51 million, with ba...

TipRanks 5d

Ligand Pharmaceuticals Earnings Call Signals Royalty-Driven Surge

Ligand Pharmaceuticals Inc ((LGND)) has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock powe...

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

More LGND News

Simply Wall St 6d

Ligand Pharmaceuticals Could Be 9% Undervalued As Earnings And Guidance Hold

Advertisement Why Ligand Pharmaceuticals Stock Is Back on Investors’ Radar Ligand Pharmaceuticals (LGND) is in focus after reporting second quarter 2026 resul...

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.